Cargando…

Testing times for dementia: a community survey identifying contemporary barriers to risk reduction and screening

BACKGROUND: Advances in pharmacological and non-pharmacological dementia interventions may mean future dementia prevention incorporates a combination of targeted screening and lifestyle modifications. Elucidating potential barriers which may prevent community engagement with dementia prevention init...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Nikki-Anne, Peters, Ruth, Lautenschlager, Nicola T., Anstey, Kaarin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088195/
https://www.ncbi.nlm.nih.gov/pubmed/37038211
http://dx.doi.org/10.1186/s13195-023-01219-4
_version_ 1785022520206819328
author Wilson, Nikki-Anne
Peters, Ruth
Lautenschlager, Nicola T.
Anstey, Kaarin J.
author_facet Wilson, Nikki-Anne
Peters, Ruth
Lautenschlager, Nicola T.
Anstey, Kaarin J.
author_sort Wilson, Nikki-Anne
collection PubMed
description BACKGROUND: Advances in pharmacological and non-pharmacological dementia interventions may mean future dementia prevention incorporates a combination of targeted screening and lifestyle modifications. Elucidating potential barriers which may prevent community engagement with dementia prevention initiatives is important to maximise the accessibility and feasibility of these initiatives across the lifespan. METHODS: Six hundred seven adults aged over 18 years completed a 54-item, multiple-choice survey exploring contemporary attitudes towards, and barriers to, dementia risk reduction and screening relative to other common health conditions. Participants were sourced from Australia’s largest, paid, data analytics service (ORIMA). RESULTS: Finances (p = .009), poor motivation (p = .043), and time (p ≤ .0001) emerged as significant perceived barriers to dementia risk reduction behaviours. Lack of time was more likely to be reported by younger, relative to older, participants (p ≤ .0001), while females were more likely than males to report financial (p = .019) and motivational (p = .043) factors. Binary logistic regression revealed willingness to undertake dementia testing modalities was significantly influenced by gender (genetic testing, p = .012; saliva, p = .038, modifiable risk factors p = .003), age (cognitive testing, p ≤ .0001; blood, p = .010), and socio-economic group (retinal imaging, p = .042; modifiable risk-factor screening, p = .019). Over 65% of respondents felt adequately informed about risk reduction for at least one non-dementia health condition, compared to 30.5% for dementia. CONCLUSIONS: This study found perceived barriers to dementia risk reduction behaviours, and the willingness to engage in various dementia testing modalities, was significantly associated with socio-demographic factors across the lifespan. These findings provide valuable insight regarding the accessibility and feasibility of potential methods for identifying those most at risk of developing dementia, as well as the need to better promote and support wide-scale engagement in dementia risk reduction behaviours across the lifespan. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01219-4.
format Online
Article
Text
id pubmed-10088195
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100881952023-04-12 Testing times for dementia: a community survey identifying contemporary barriers to risk reduction and screening Wilson, Nikki-Anne Peters, Ruth Lautenschlager, Nicola T. Anstey, Kaarin J. Alzheimers Res Ther Research BACKGROUND: Advances in pharmacological and non-pharmacological dementia interventions may mean future dementia prevention incorporates a combination of targeted screening and lifestyle modifications. Elucidating potential barriers which may prevent community engagement with dementia prevention initiatives is important to maximise the accessibility and feasibility of these initiatives across the lifespan. METHODS: Six hundred seven adults aged over 18 years completed a 54-item, multiple-choice survey exploring contemporary attitudes towards, and barriers to, dementia risk reduction and screening relative to other common health conditions. Participants were sourced from Australia’s largest, paid, data analytics service (ORIMA). RESULTS: Finances (p = .009), poor motivation (p = .043), and time (p ≤ .0001) emerged as significant perceived barriers to dementia risk reduction behaviours. Lack of time was more likely to be reported by younger, relative to older, participants (p ≤ .0001), while females were more likely than males to report financial (p = .019) and motivational (p = .043) factors. Binary logistic regression revealed willingness to undertake dementia testing modalities was significantly influenced by gender (genetic testing, p = .012; saliva, p = .038, modifiable risk factors p = .003), age (cognitive testing, p ≤ .0001; blood, p = .010), and socio-economic group (retinal imaging, p = .042; modifiable risk-factor screening, p = .019). Over 65% of respondents felt adequately informed about risk reduction for at least one non-dementia health condition, compared to 30.5% for dementia. CONCLUSIONS: This study found perceived barriers to dementia risk reduction behaviours, and the willingness to engage in various dementia testing modalities, was significantly associated with socio-demographic factors across the lifespan. These findings provide valuable insight regarding the accessibility and feasibility of potential methods for identifying those most at risk of developing dementia, as well as the need to better promote and support wide-scale engagement in dementia risk reduction behaviours across the lifespan. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01219-4. BioMed Central 2023-04-10 /pmc/articles/PMC10088195/ /pubmed/37038211 http://dx.doi.org/10.1186/s13195-023-01219-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wilson, Nikki-Anne
Peters, Ruth
Lautenschlager, Nicola T.
Anstey, Kaarin J.
Testing times for dementia: a community survey identifying contemporary barriers to risk reduction and screening
title Testing times for dementia: a community survey identifying contemporary barriers to risk reduction and screening
title_full Testing times for dementia: a community survey identifying contemporary barriers to risk reduction and screening
title_fullStr Testing times for dementia: a community survey identifying contemporary barriers to risk reduction and screening
title_full_unstemmed Testing times for dementia: a community survey identifying contemporary barriers to risk reduction and screening
title_short Testing times for dementia: a community survey identifying contemporary barriers to risk reduction and screening
title_sort testing times for dementia: a community survey identifying contemporary barriers to risk reduction and screening
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088195/
https://www.ncbi.nlm.nih.gov/pubmed/37038211
http://dx.doi.org/10.1186/s13195-023-01219-4
work_keys_str_mv AT wilsonnikkianne testingtimesfordementiaacommunitysurveyidentifyingcontemporarybarrierstoriskreductionandscreening
AT petersruth testingtimesfordementiaacommunitysurveyidentifyingcontemporarybarrierstoriskreductionandscreening
AT lautenschlagernicolat testingtimesfordementiaacommunitysurveyidentifyingcontemporarybarrierstoriskreductionandscreening
AT ansteykaarinj testingtimesfordementiaacommunitysurveyidentifyingcontemporarybarrierstoriskreductionandscreening